ScholarLens Back to search
2019•PubMedOpen access

[Comparison of haploidentical hematopoietic stem cell transplantation and matched-sibling donor transplantation for the treatment of paroxysmal nocturnal hemoglobinuria].

Liu Lm, Zhou Hf, Wang Qy, Qiu Hy, Tang Xw, Yongsheng Han, Fu Cc, Jin Zm, Chen Sn, An Sun, Maohua Miao, Dapeng Wu

Open full text 5 citations

Abstract

The preliminary results indicated that haplo-HSCT was a feasible choice for PNH with favorable outcomes, haplo-HSCT and MSD-HSCT produced similar therapeutic efficacy.

About this research paper

What this paper is about

The preliminary results indicated that haplo-HSCT was a feasible choice for PNH with favorable outcomes, haplo-HSCT and MSD-HSCT produced similar therapeutic efficacy.

Why it matters

OpenAlex reports 5 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

The preliminary results indicated that haplo-HSCT was a feasible choice for PNH with favorable outcomes, haplo-HSCT and MSD-HSCT produced similar therapeutic efficacy.

Key concepts: Paroxysmal nocturnal hemoglobinuria, Hematopoietic stem cell transplantation, Medicine, Internal medicine, Transplantation, Gastroenterology, CD34, Graft-versus-host disease

Related papers

Related paper 1Related paper 2
Back to paper searchBrowse research topicsOriginal source
[Comparison of haploidentical hematopoietic stem cell transplantation and matched-sibling donor transplantation for the treatment of paroxysmal nocturnal hemoglobinuria]. — Research Paper | ScholarLens